The deletion of this gene substantially reduces the risk of oHSV-mediated neurovirulence by preventing viral protein synthesis in healthy cells, while maintaining its competence in cells with impaired PKR function, such as cancer cells [88,89]. This evidence concerns the gene EIF2AK2 and cancer.